Adam I. Marcus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adam I. Marcus has a total of 199 co-authors. Here are the top co-authors by number of shared publications:
- Melissa Gilbert-Ross
Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory, Emory University School of Medicine, Atlanta, USA
33 shared publications - Wei Zhou
The Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
31 shared publications - Haian Fu
Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
30 shared publications - Bhakti Dwivedi
Winship Cancer Institute, Emory University, Atlanta, GA, USA
29 shared publications - Chang-Soo Seong
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia
27 shared publications - Henry Claussen
Emory Integrated Computational Core, Emory University School of Medicine, Atlanta, Georgia
27 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legends from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Legends for Supplementary Figures
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legends from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Legends for Supplementary Figures
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Figure S2 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Figure S2 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Figure S5 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Figure S5 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Figure S3 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Figure S3 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
List of upregulated transcripts in KL vs. KP invasive spheroids with respect to K>C.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
List of upregulated transcripts in KL vs. KP invasive spheroids with respect to K>C.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Video 1 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Invasive phenotyping of K, KL, and KP HBECs
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 1 from Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Invasive phenotyping of K, KL, and KP HBECs
- Open Access
- 6 April 2026
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24  (1)
Leader cell myosin 10 controls adhesion dynamics, invasion, and EMT pathway activation
The epithelial-to-mesenchymal transition (EMT) relies on cytoskeletal remodeling that drives cell migration and invasion. Leader cells are a highly invasiv
- 6 April 2026
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24  (1)
Open AccessLeader cell myosin 10 controls adhesion dynamics, invasion, and EMT pathway activation
The epithelial-to-mesenchymal transition (EMT) relies on cytoskeletal remodeling that drives cell migration and invasion. Leader cells are a highly invasiv
- Open Access
- 1 November 2025
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 36  (11)
Metabolic programming defines oxygen-sensitive subpopulation hierarchies and patterning in collective invasion
Phenotypic heterogeneity—distinct molecular and behavioral variations within a population—significantly influences collective invasion and tumor progression. Here, we use a molecular approach to explore how the underlying metabolic heterogeneity in non-small cell lung cancer (NSCLC) influences invasion and pack patterning. Assessment of three-dimensional (3D) pack patterning revealed invasive heterogeneity across NSCLC cell lines and patient-derived samples. Flow cytometry identified IL13RA2 as a biomarker for invasive potential, enabling isolation of subpopulations with distinct invasive characteristics. By integrating a cell surface biomarker (IL13RA2±) with mitochondrial membrane potential (TMRM), we identified and isolated three distinct subpopulations. Two-dimensional (2D) analyses revealed differences in mitochondrial polarity and transcriptional programs associated with migration and oxygensensitivity. In 3D, these subpopulations invaded with distinct patterns, from contiguous circular packs to structured chains. Assessments under varied oxygen tension demonstrated that oxygen availability and subpopulation metabolism together influence collective invasion patterning. When recombined at ratios recapitulating the original population, both stochastic and opportunistic cooperative dynamics emerged, dependent on subpopulation composition and oxygen levels. Our molecular approach, integrating cell surface and metabolic characteristics, enables the isolation of unique subpopulations and demonstrates that phenotypic and metabolic heterogeneity, population composition, and oxygen availability collectively pattern invasion packs and drive collective invasion.
- 1 November 2025
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 36  (11)
Open AccessMetabolic programming defines oxygen-sensitive subpopulation hierarchies and patterning in collective invasion
Phenotypic heterogeneity—distinct molecular and behavioral variations within a population—significantly influences collective invasion and tumor progression. Here, we use a molecular approach to explore how the underlying metabolic heterogeneity in non-small cell lung cancer (NSCLC) influences invasion and pack patterning. Assessment of three-dimensional (3D) pack patterning revealed invasive heterogeneity across NSCLC cell lines and patient-derived samples. Flow cytometry identified IL13RA2 as a biomarker for invasive potential, enabling isolation of subpopulations with distinct invasive characteristics. By integrating a cell surface biomarker (IL13RA2±) with mitochondrial membrane potential (TMRM), we identified and isolated three distinct subpopulations. Two-dimensional (2D) analyses revealed differences in mitochondrial polarity and transcriptional programs associated with migration and oxygensensitivity. In 3D, these subpopulations invaded with distinct patterns, from contiguous circular packs to structured chains. Assessments under varied oxygen tension demonstrated that oxygen availability and subpopulation metabolism together influence collective invasion patterning. When recombined at ratios recapitulating the original population, both stochastic and opportunistic cooperative dynamics emerged, dependent on subpopulation composition and oxygen levels. Our molecular approach, integrating cell surface and metabolic characteristics, enables the isolation of unique subpopulations and demonstrates that phenotypic and metabolic heterogeneity, population composition, and oxygen availability collectively pattern invasion packs and drive collective invasion.